6 Stocks You Can Invest In for Under $50

For many people, investing is about capitalizing on the massive return potential of equities at a relative bargain. Investing for this goal requires foresight and timing.

Invest: In 5 Years, These 2 Stocks Will Be More Valuable Than Apple

Learn: 4 Genius Things All Wealthy People Do With Their Money

This is where equities valued at less than $50 come into play. They are often inexpensive enough to allow for the accumulation of a sizable share count and, at the same time, poised for tremendous growth or expansion due to potentially favorable conditions and bullish momentum.

The following six stocks won’t remain under $50 for long — in fact, one that is typically priced at under $50 is trading just over $51 today — but all are companies you should take a flyer on now, before they flourish.

Also: 3 Types of Investments Predicted To Plummet in Value in Summer 2024

Sponsored: Protect Your Wealth With A Gold IRA. Take advantage of the timeless appeal of gold in a Gold IRA recommended by Sean Hannity.

Palantir Technologies Inc. (NYSE: PLTR)

• Stock price today: ~$26

A risky buy, not because of concerns about future growth, but because shares have already risen by 30% since January after posting impressive 2023 Q4 and 2024 Q1 earnings reports and a net profit for the sixth straight quarter in May.

AI technology continues to grow without an end in sight, and some notable investors have taken note of Palantir’s expansion into both government contracts and the corporate sector. Cathie Wood recently added more Palantir stock to her ARK Investment Management portfolio, and the company is working on software capabilities with the U.S. Special Operations Command. Shares have been stuck in the $20-$25 range but are currently trading slightly above that.

Pfizer (NYSE: PFE)

• Stock price today: ~$28

A stock that has declined over the past year is big pharma company Pfizer, whose revenue and profits have taken a hit due to a drop in demand for its COVID-19 vaccines. But the company is too established and should steadily rebound despite forthcoming patent expirations for some of its top-selling products.

The Motley Fool has been pushing Pfizer for some months now, citing the company’s dedication to launching new products, growing its dividend (currently sitting at 6.6%), and adding business development deals that could add $25 billion to its annual revenue by 2030.

Marathon Digital Holdings Inc. (NASDAQ: MARA)

• Stock price today: ~$21.40

If Bitcoin maintains in an upward trend, the fast-growing Marathon Digital (NASDAQ: MARA) stock is likely to quadruple sooner than projected, according to InvestorPlace. The Bitcoin (BTC-USD) miner has aggressive expansion plans that are supported by solid fundamentals.

Marathon Digital closed the first quarter with a cash cushion of $1.6 billion (including digital assets), paving the way for aggressive growth and diversification, like its recent Kaspa mining venture. At just over $21 per share, MARA stock seems inexpensive, given the growth prospects.

Ford Motor Co. (NYSE: F)

• Stock price today: ~$13

Why on Earth would you invest in one of the old-school auto companies that is delaying production of some of its planned electric vehicle models and has seen its stock drop 16% over the past year? As InvestorPlace mentions, Ford is cheap (around $13 a share), currently trades at only 13 times future earnings estimates, and pays a dividend of 15 cents per share.

The company will eventually adapt to EV production concerns while continuing to produce models that never go out of style, such as the F-150 pickup and Mustang.

Viking Therapeutics, Inc. (NASDAQ: VKTX)

• Stock price today: ~$51

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a biopharmaceutical business that creates treatments for people with endocrine and metabolic ailments. According to Insider Monkey, the company’s share price has gained 146% in the last 52 months, yet it still typically trades below $50 (however, today, it’s slightly above $51), making it a winner for healthcare companies to buy.

Viking Therapeutics shares have risen since the company published forward-looking findings from its Phase 2 clinical study of VK2735, a weight-loss medicine. Although it recorded a net loss of $27.4 million in Q1 2024 (a $0.26 loss per share of $0.26), VKTX attributed the negative returns to an increase in R&D.

DraftKings (NASDAQ: DKNG)

• Stock price today: ~$37.70

Even the biggest hermits will concede that sports betting is everywhere. Since sports gambling was legalized in 2018, 38 states (plus Washington, D.C. and Puerto Rico), have legalized the activity. Typically done on apps like DraftKings, betting has become more accessible and pervasive, thanks to endless advertising.

But is investing in DraftKings a good bet, as it remains under $50?  DKNG stock has increased 77% over the last year and is up 27% in 2024. The business posted $3.67 billion in revenue in 2023, around 18% of the $20 billion addressable market, per InvestorPlace. Revenue could further grow if the rest of the United States comes on board with sports wagering.

This article originally appeared on GOBankingRates.com : 6 Stocks You Can Invest In for Under $50